FDA Inspection 1204327 — Jonathan L. Liss, MD
The FDA completed an inspection of Jonathan L. Liss, MD on April 27, 2023 in Columbus, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 27, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Columbus, GA (United States)
Additional Details
Clinical Investigator (CI)